This was reinforced by our studies in the EC-Bmpr2-/- mice where targeted expression of Foxf1 using an AAV vector engineered to be delivered to lung EC prevented persistent pulmonary hypertension during reoxygenation after hypoxia. Here, FOXF1 is linked to pulmonary arterial hypertension.